AWM
TRML

Altium Wealth Management’s Tourmaline Bio TRML Stock Holding History

Altium Wealth Management’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$268K Hold
5,952
– – 0.02% 315
2022
Q1 		$586K Hold
5,952
– – 0.04% 237
2021
Q4 		$910K Buy
+5,952
New +$881K 0.06% 162

Other funds holding TRML

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Altium Wealth Management's TRML Position: Q2 2022 in Review

Altium Wealth Management held its Tourmaline Bio (TRML) position steady in Q2 2022 at 5,952 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #315.

Altium Wealth Management first reported a position in TRML in Q4 2021 and has held it in 3 quarters since. The position peaked at $910K in Q4 2021. 59 funds tracked by Wall St. Rank hold TRML as of Q2 2022.

  • Altium Wealth Management held 5,952 shares of Tourmaline Bio worth $268K as of Q2 2022.
  • Altium Wealth Management left its Tourmaline Bio share count unchanged in Q2 2022.
  • Tourmaline Bio made up 0.02% of Altium Wealth Management's portfolio in Q2 2022, its #315 holding.
  • Altium Wealth Management first reported a position in Tourmaline Bio in Q4 2021 and has held it in 3 quarters since.
  • Altium Wealth Management's Tourmaline Bio position peaked at $910K in Q4 2021.
  • 59 funds tracked by Wall St. Rank held Tourmaline Bio as of Q2 2022.

Based on Altium Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.